Gilles BRISSON, Chairman, former Chairman of the Supervisory Board at Aventis Pharma SA

Irina STAATZ-GRANZER, Vice-Chairman, Founder and CEO of Staatz Business Development & Strategy, former CEO of Scil Technology

Alta BioPharma Partners II, LP, represented by Ekaterina SMIRNYAGINA, Venture Partner at Alta Partners 

NOVO NORDISK A/S, represented by Lars Fruergaard JØRGENSEN, Senior Vice President - IT & Corporate Development at Novo Nordisk A/S

Patrick LANGLOIS, General Partner of PJL Conseils and Director in several biopharmaceutical companies - notably Shire plc - former CFO of Rhone-Poulenc as well as Group Executive Vice President and CFO of Aventis

Philippe POULETTY, former CEO and founder of Sangstat (Genzyme)

     
Bernard MALISSEN, Chairman of the Scientific Advisory Board, and the Fonds Stratégique d’Investissement (French sovereign fund, “FSI”), represented by Olivier MARTINEZ, are observers to the Supervisory Board.